Status:
UNKNOWN
The Development of Human Immunologic Assays Specific to Folate Receptor Antigen
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
10-90 years
Phase:
NA
Brief Summary
Ovarian cancer has the highest mortality rate of gynecologic malignancies and the overall 5-year survival rate of ovarian cancer is only 20-30%. Additionally, the incidence of ovarian cancer has incre...
Detailed Description
Incidence of Ovarian Cancer Ovarian cancer is the first mortality rate of gynecologic malignancies with an overall 5-year survival rate of only 20-30%. It became a more and more important disease in ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Ovarian cancer patients
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00155935
Start Date
January 1 2004
End Date
December 1 2008
Last Update
August 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan Univ. Hospital
Taipei, Taiwan